Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
6,171
datasets available to search
ShareScore release 0.9.0
Dataset results
6,171 results for “mutant”
iMagemHTT- 009- FIH Evaluation of Novel Mutant Huntingtin PET Radioligand [11C]CHDI-00491009
ClinicalTrials.gov study NCT06634628. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer
ClinicalTrials.gov study NCT04762979. IPD Sharing: NO. Countries: 1. Publications: 0.
Defactinib, Avutometinib and Nivolumab for the Treatment of Anti-PD1 Refractory LKB1-Mutant Advanced Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06495125. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase 1b/2 Study of Retaspimycin HCl (IPI-504) in Combination With Everolimus in KRAS Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT01427946. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ipatasertib + Pertuzumab +Trastuzumab in Advanced HER2+ PI3KCA-mutant Breast Cancer Patients
ClinicalTrials.gov study NCT04253561. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Tipifarnib in Patients With Previously-Treated, Advanced, HRAS Mutant Urothelial Carcinoma
ClinicalTrials.gov study NCT02535650. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Intrathecal Pemetrexed for Leptomeningeal Metastasis in EGFR-Mutant NSCLC
ClinicalTrials.gov study NCT05805631. IPD Sharing: NO. Countries: 0. Publications: 0.
Low Dose Daily Erlotinib in Combination With High Dose Twice Weekly Erlotinib in Patients With EGFR-Mutant Lung Cancer
ClinicalTrials.gov study NCT01967095. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ferroptosis Study in SF3B1-mutant Myelodysplastic Syndromes (FerMDS)
ClinicalTrials.gov study NCT05924074. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Study of Osimertinib in Combination With Selumetinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT03392246. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of BL-M07D1 vs Pembrolizumab-platinum Chemotherapy in First-line Treatment of HER2-mutant Advanced or Metastatic Non-squamous NSCLC
ClinicalTrials.gov study NCT07178795. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ORIC-114 in Combination with Subcutaneous Amivantamab in Patients with EGFR Exon20 Insertion Mutant NSCLC
ClinicalTrials.gov study NCT06816992. IPD Sharing: NO. Countries: 3. Publications: 0.
Trial of Vemurafenib and Cobimetinib in Patients With Advanced BRAFV600 Mutant Melanoma
ClinicalTrials.gov study NCT02427893. IPD Sharing: Not stated. Countries: 1. Publications: 0.
All-Trans Retinoic Acid (ATRA) Plus PD-1 Inhibition in Recurrent IDH-Mutant Glioma
ClinicalTrials.gov study NCT05345002. IPD Sharing: NO. Countries: 1. Publications: 0.
The Efficacy and Safety of Fruquintinib Plus FOLFIRI/FOLFOX as Second-line Treatment in Patients With RAS-mutant Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT05634590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Binimetinib and Imatinib for Unresectable Stage III-IV KIT-Mutant Melanoma
ClinicalTrials.gov study NCT04598009. IPD Sharing: NO. Countries: 1. Publications: 0.
ELVN-002 in HER2 Mutant Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT05650879. IPD Sharing: NO. Countries: 7. Publications: 0.
Temporally-modulated Pulsed Radiation Therapy (TMPRT) After Prior EBRT for Recurrent IDH-mutant Gliomas
ClinicalTrials.gov study NCT05393258. IPD Sharing: NO. Countries: 1. Publications: 0.
RO5126766 for Patients With Advanced KRAS-Mutant Lung Cancer
ClinicalTrials.gov study NCT03681483. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Afatinib and Selumetinib in Advanced KRAS Mutant and PIK3CA Wildtype Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT02450656. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.